Small renal masses: Toward more rational treatment

Cleveland Clinic Journal of Medicine

Volumn 78, Issue 8, 2011, Pages 539-547

  Thomas, Anil A ^a   Campbell, Steven C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; KIDNEY; KIDNEY TUMOR; NEPHRECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; WATCHFUL WAITING;

ABLATION TECHNIQUES; BIOPSY; HUMANS; KIDNEY; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEPHRECTOMY; TOMOGRAPHY, X-RAY COMPUTED; WATCHFUL WAITING;

EID: 80052683232     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.78a.10176     Document Type: Review

References (38)

1. Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J 2008; 14:288-301.
2. Lane BR, Campbell SC. Management of small renal masses. AUA Update Series 2009; 28:313-324.
3. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer 2004; 100:738-745.
4. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98:1331-1334.
5. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 2003; 170:2217-2220.
6. Russo P. Should elective partial nephrectomy be performed for re-nal cell carcinoma >4 cm in size? Nat Clin Pract Urol 2008; 5:482-483.
7. Thomas AA, Aron M, Hernandez AV, Lane BR, Gill IS. Laparoscopic partial nephrectomy in octogenarians. Urology 2009; 74:1042-1046.
8. Thompson RH, Kurta JM, Kaag M, et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 2009; 181:2033-2036.
9. Mues AC, Landman J. Small renal masses: current concepts regarding the natural history and reflections on the American Urological Association guidelines. Curr Opin Urol 2010; 20:105-110.
10. Patard JJ, Bensalah K, Vincendeau S, Rioux-Leclerq N, Guillé F, Lobel B. [Correlation between the mode of presentation of renal tumors and patient survival]. Prog Urol 2003; 13:23-28.
11. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373:1119-1132.
12. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy-a renaissance? J Urol 2008; 179:20-27.
13. Samplaski MK, Zhou M, Lane BR, Herts B, Campbell SC. Renal mass sampling: an enlightened perspective. Int J Urol 2011; 18:5-19.
14. Tan MH, Rogers CG, Cooper JT, et al. Gene expression profiling of renal cell carcinoma. Clin Cancer Res 2004; 10:6315S-6321S.
15. Miller DC, Hollingsworth JM, Hafez KS, Daignault S, Hollenbeck BK. Partial nephrectomy for small renal masses: an emerging quality of care concern? J Urol 2006; 175:853-857.
16. Lane BR, Poggio ED, Herts BR, Novick AC, Campbell SC. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J Urol 2009; 182:435-444.
17. Campbell SC, Novick AC, Belldegrun A, et al. Practice Guidelines Committee of the American Urological Association. Guideline for management of the clinical T1 renal mass. J Urol 2009; 182:1271-1279.
18. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7:735-740.
19. Boorjian SA, Uzzo RG. The evolving management of small renal masses. Curr Oncol Rep 2009; 11:211-217.
20. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999; 162:1930-1933.
21. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol 2000; 163:730-736.
22. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006; 175:425-431.
23. Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors- is there a difference in mortality and cardiovascular outcomes? J Urol 2009; 181:55-61.
24. Thompson RH, Boorjian SA, Lohse CM, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol 2008; 179:468-471.
25. Thomas AA, Demirjian S, Lane BR, et al. Acute kidney injury: novel biomarkers and potential utility for patient care in urology. Urology 2011; 77:5-11.
26. Hinshaw JL, Shadid AM, Nakada SY, Hedican SP, Winter TC 3rd, Lee FT Jr. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses. AJR Am J Roentgenol 2008; 191:1159-1168.
27. Sterrett SP, Nakada SY, Wingo MS, Williams SK, Leveillee RJ. Renal thermal ablative therapy. Urol Clin North Am 2008; 35:397-414.
28. Hafron J, Kaouk JH. Ablative techniques for the management of kidney cancer. Nat Clin Pract Urol 2007; 4:261-269.
29. Matin SF, Ahrar K. Nephron-sparing probe ablative therapy: longterm outcomes. Curr Opin Urol 2008; 18:150-156.
30. Berger A, Kamoi K, Gill IS, Aron M. Cryoablation for renal tumors: current status. Curr Opin Urol 2009; 19:138-142.
31. Nguyen CT, Campbell SC. Salvage of local recurrence after primary thermal ablation for small renal masses. Expert Rev Anticancer Ther 2008; 8:1899-1905.
32. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 2000; 174:323-331.
33. Carraway WA, Raman JD, Cadeddu JA. Current status of renal radiofrequency ablation. Curr Opin Urol 2009; 19:143-147.
34. Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008; 113:2671-2680.
35. Kunkle DA, Kutikov A, Uzzo RG. Management of small renal masses. Semin Ultrasound CT MR 2009; 30:352-358.
36. Kunkle DA, Crispen PL, Chen DY, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol 2007; 177:849-853.
37. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008; 179:1227-1233.
38. Jewett MA, Zuniga A. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am 2008; 35:627- 634.